Harmony Biosciences Holdings (HRMY) stock news · P/E 12, rev $868.5M
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
This HRMY news page leads with what Harmony Biosciences Holdings filed — not a scraped headline mill.
No cached 8-K sentence for HRMY yet. We will not pad this page with generic market recap.
Latest reported HRMY revenue for 2025-12-31 was $868.5M. Net income was $158.7M. Revenue was up 21.5% from 2024-12-31 to 2025-12-31. HRMY currently screens at market cap $1.96B and trailing P/E 12.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the HRMY stock page; for the tape open the quote page.
HRMY stock news FAQ
What are HRMY's latest revenue and net income?
Latest cached Harmony Biosciences Holdings (HRMY) revenue for Dec 31, 2025 was $868.5M. Net income was $158.7M. Statements: https://lician.com/financials/hrmy
How did HRMY revenue change from the prior cached period?
Cached Harmony Biosciences Holdings (HRMY) revenue was up 21.5% from $714.7M (Dec 31, 2024) to $868.5M (Dec 31, 2025). Statements: https://lician.com/financials/hrmy
What is HRMY's P/E ratio?
Harmony Biosciences Holdings (HRMY) trailing P/E is 12.3 on the latest cached fundamentals snapshot.
What is HRMY's market cap?
Harmony Biosciences Holdings (HRMY) market cap is $1.96B on the latest cached fundamentals snapshot.
What kind of company is HRMY?
Harmony Biosciences Holdings (HRMY) is a biotechnology company listed on NASDAQ.
Where is HRMY stock news listed?
Cached stock news for Harmony Biosciences Holdings (HRMY) is listed at https://lician.com/news/hrmy. Filings: https://lician.com/sec/hrmy
Not investment advice.